A Comparison of the Efficacy and Safety of ULTRACET (Tramadol HCl/Acetaminophen) Versus Placebo for the Acute Treatment of Migraine Headache Pain.

Trial Profile

A Comparison of the Efficacy and Safety of ULTRACET (Tramadol HCl/Acetaminophen) Versus Placebo for the Acute Treatment of Migraine Headache Pain.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 May 2009

At a glance

  • Drugs Tramadol/paracetamol (Primary)
  • Indications Acute pain; Migraine
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 26 May 2009 Actual patient number changed from 305 to 375 as reported by ClinicalTrials.gov.
    • 05 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top